WE ARE
We’re more than just breakthrough models. We operationalize the most advanced GI models through end-to-end solutions that fit into clinical practice and research workflows.
Our modular platform serves as the foundation fordelivering advanced models through a secure, interoperable API pipeline that integrates seamlessly into existing systems.
Our platform-centric approach enables Dova to partner with agility across domains, with any organization.
Partner With UsSharper Insights. Smarter Decisions.
DovaVision uses advanced AI to automate scoring and rapidly analyze Ulcerative Colitis (UC) disease severity from endoscopy videos.
Designed for both research and clinical trials, it ensures enriched, consistent, objective, and efficient evaluation of UC
Granular Disease Evaluation
Quantify subtle variations in inflammation, ulceration, and other disease markers across different regions of the colon.
Repeatable Precision
Reduce inter-observer variability, improving analysis consistency and real-world decision-making
Deep Feature Mapping
Analyze disease features that underpin scoring, enhancing precision and transparency of disease grading.
Dynamic Frame-level Analysis
Generate dynamic severity analysis across the full procedure —available as raw data for further analysis and intuitive visual outputs.
FOR CLINICAL TRIALS
DovaVision’s explainable AI enables interpretability to reveal subtle patterns and changes in disease activity that the human eye may miss. These insights power more informed decisions in both clinical development and post-marketing strategies.
Automatically flag low-quality or non-adherent videos across sites to reduce protocol deviations and costly post-trial corrections. DovaVision drives proactive oversight from day one.
Automated video analysis runs in parallel with clinical workflows, reducing human burden and enabling seamless deployment across multi-center, global studies.
DovaVision delivers consistent AI-powered assessments —ensuring the same result for the same input, every time. This eliminates inter-observer variability and supports reliable, trial-wide data integrity.
WE ARE
DovaVision unlocks deeper biological and therapeutic insights from endoscopic video, using explainable AI to surface subtle changes and hidden disease signals.
Detect subtle shifts. Uncover hidden patterns.
DovaVision’s explainable AI identifies nuanced biological and procedural signals from endoscopic data—offering new layers of insight into drug response, disease progression, and therapeutic impact.
Quantify treatment effects with objective AI endpoints.
Support biomarker discovery with visual and functional data generated from video-based scoring. DovaVision can support surrogate endpoints and enhance exploratory analyses.
Quantify response trajectories over time.
DovaVision enables consistent scoring across visits allowing researchers to monitor disease progression or therapeutic response with objective, reproducible endpoints over time. Ideal for longitudinal analysis, outcomes-based validation, and identifying early signals of efficacy.
Integrate visual data with multi-omic profiles
Pair DovaVision’s imaging biomarkers with other data sets such as genomic, transcriptomic, and clinical data to explore disease pathways, discover new biomarkers, and personalize treatments.
DovaSound is an AI-powered product currently under development, designed to enhance the clinical utility of intestinal ultrasound (IUS) for monitoring Inflammatory Bowel Disease (IBD). Built for both research and real-world care, DovaSound brings objectivity, automation, and clinical relevance to IUS—making it a smarter, more scalable alternative to traditional approaches.
DovaSound is being developed to meet rising demand for non-invasive, scalable tools that support earlier intervention, more frequent monitoring, and improved access across diverse patient populations. It is designed to reduce variability in interpretation, automate key measurements, and deliver standardized, unbiased insights—enabling faster decisions and greater precision in both care and research settings.
DovaSound leverages Dova’s validated AI infrastructure—benefiting from prior development pathways, regulatory groundwork, and partnerships with global experts and institutions. Government-backed and KOL-supported, it’s positioned to accelerate adoption in both clinical and research environments.